5-147829667-A-G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001379610.1(SPINK1):​c.56-37T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00971 in 1,590,006 control chromosomes in the GnomAD database, including 108 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign,risk factor (★★).

Frequency

Genomes: 𝑓 0.0076 ( 6 hom., cov: 33)
Exomes 𝑓: 0.0099 ( 102 hom. )

Consequence

SPINK1
NM_001379610.1 intron

Scores

2

Clinical Significance

Benign/Likely benign; risk factor criteria provided, multiple submitters, no conflicts B:5O:1

Conservation

PhyloP100: -0.216

Publications

14 publications found
Variant links:
Genes affected
SPINK1 (HGNC:11244): (serine peptidase inhibitor Kazal type 1) The protein encoded by this gene is a trypsin inhibitor, which is secreted from pancreatic acinar cells into pancreatic juice. It is thought to function in the prevention of trypsin-catalyzed premature activation of zymogens within the pancreas and the pancreatic duct. Mutations in this gene are associated with hereditary pancreatitis and tropical calcific pancreatitis. [provided by RefSeq, Oct 2008]
SPINK1 Gene-Disease associations (from GenCC):
  • hereditary chronic pancreatitis
    Inheritance: AD, Unknown Classification: STRONG, SUPPORTIVE, NO_KNOWN Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • tropical pancreatitis
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BP6
Variant 5-147829667-A-G is Benign according to our data. Variant chr5-147829667-A-G is described in ClinVar as [Likely_benign, risk_factor]. Clinvar id is 239507.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population sas. GnomAd4 allele frequency = 0.0076 (1158/152330) while in subpopulation SAS AF = 0.0153 (74/4832). AF 95% confidence interval is 0.0125. There are 6 homozygotes in GnomAd4. There are 580 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 1158 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPINK1NM_001379610.1 linkc.56-37T>C intron_variant Intron 1 of 3 ENST00000296695.10 NP_001366539.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPINK1ENST00000296695.10 linkc.56-37T>C intron_variant Intron 1 of 3 1 NM_001379610.1 ENSP00000296695.5 P00995
SPINK1ENST00000510027.2 linkc.56-37T>C intron_variant Intron 1 of 2 3 ENSP00000427376.1 D6RIU5

Frequencies

GnomAD3 genomes
AF:
0.00761
AC:
1158
AN:
152212
Hom.:
6
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00234
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00419
Gnomad ASJ
AF:
0.00144
Gnomad EAS
AF:
0.00559
Gnomad SAS
AF:
0.0155
Gnomad FIN
AF:
0.0177
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.00998
Gnomad OTH
AF:
0.00955
GnomAD2 exomes
AF:
0.00825
AC:
2055
AN:
249204
AF XY:
0.00898
show subpopulations
Gnomad AFR exome
AF:
0.00203
Gnomad AMR exome
AF:
0.00189
Gnomad ASJ exome
AF:
0.000897
Gnomad EAS exome
AF:
0.00219
Gnomad FIN exome
AF:
0.0171
Gnomad NFE exome
AF:
0.00873
Gnomad OTH exome
AF:
0.00724
GnomAD4 exome
AF:
0.00993
AC:
14282
AN:
1437676
Hom.:
102
Cov.:
27
AF XY:
0.0102
AC XY:
7332
AN XY:
716858
show subpopulations
African (AFR)
AF:
0.00109
AC:
36
AN:
32986
American (AMR)
AF:
0.00224
AC:
100
AN:
44644
Ashkenazi Jewish (ASJ)
AF:
0.00112
AC:
29
AN:
25988
East Asian (EAS)
AF:
0.00410
AC:
162
AN:
39486
South Asian (SAS)
AF:
0.0184
AC:
1579
AN:
85702
European-Finnish (FIN)
AF:
0.0158
AC:
831
AN:
52564
Middle Eastern (MID)
AF:
0.00175
AC:
10
AN:
5722
European-Non Finnish (NFE)
AF:
0.0100
AC:
10963
AN:
1091038
Other (OTH)
AF:
0.00961
AC:
572
AN:
59546
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
646
1292
1938
2584
3230
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
442
884
1326
1768
2210
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00760
AC:
1158
AN:
152330
Hom.:
6
Cov.:
33
AF XY:
0.00779
AC XY:
580
AN XY:
74500
show subpopulations
African (AFR)
AF:
0.00233
AC:
97
AN:
41566
American (AMR)
AF:
0.00418
AC:
64
AN:
15306
Ashkenazi Jewish (ASJ)
AF:
0.00144
AC:
5
AN:
3470
East Asian (EAS)
AF:
0.00541
AC:
28
AN:
5176
South Asian (SAS)
AF:
0.0153
AC:
74
AN:
4832
European-Finnish (FIN)
AF:
0.0177
AC:
188
AN:
10624
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.00998
AC:
679
AN:
68034
Other (OTH)
AF:
0.0104
AC:
22
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
57
114
170
227
284
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00720
Hom.:
1
Bravo
AF:
0.00604
Asia WGS
AF:
0.0340
AC:
119
AN:
3476

ClinVar

Significance: Benign/Likely benign; risk factor
Submissions summary: Benign:5Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Hereditary pancreatitis Benign:3Other:1
Jul 07, 2023
KCCC/NGS Laboratory, Kuwait Cancer Control Center
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Dec 26, 2023
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Feb 25, 2021
Sema4, Sema4
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:curation

- -

Mar 08, 2016
Labcorp Genetics (formerly Invitae), Labcorp
Significance:risk factor
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Nov 19, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SPINK1: BS1, BS2 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.4
DANN
Benign
0.58
PhyloP100
-0.22
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17107318; hg19: chr5-147209230; API